Immunosuppressive Agents: all 5,940 studies that test it
Page 39 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous NephropathyStatus unknownNCT02173106Phase 2
- A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial ManufacturersCompletedNCT02171208Phase 1
- Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor SourceCompletedNCT02167958Phase 1
- Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell TumorsCompletedNCT02161692Phase 2
- Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney TransplantationCompletedNCT02161237Phase 4
- Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus RituximabCompletedNCT02157181Phase 2
- Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)Status unknownNCT02154854Phase 4
- Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic LeukemiaActive, not recruitingNCT02153580Phase 1
- Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsCompletedNCT02152943Phase 1
- Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple MyelomaStatus unknownNCT02145715Phase 1/2
- Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCTCompletedNCT02144025Phase 2
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy SubjectsCompletedNCT02141425Phase 1
- The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted RecipientsCompletedNCT02134899Phase 3
- Belatacept for Renal Transplant Recipients With Delayed Graft FunctionTerminatedNCT02134288Early Phase 1
- Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisStatus unknownNCT02132234Phase 4
- Belatacept in Kidney Transplantation of Moderately Sensitized PatientsWithdrawnNCT02130817Phase 4
- PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy SubjectsCompletedNCT02130414Phase 1
- Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02129582Phase 1
- Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung CancerWithdrawnNCT02126527Phase 1
- Safety and Preliminary Efficacy Study of V404 PDS in UveitisTerminatedNCT02125266Phase 1/2
- Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate CancerCompletedNCT02125084Phase 1
- Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe AsthmaStatus unknownNCT02124226Phase 3
- Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesCompletedNCT02122081Phase 1
- Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung AdenocarcinomasCompletedNCT02120807Phase 1
- Calcineurin Inhibitor Based Immunosuppression WithdrawalCompletedNCT02117596Not applicable
- Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy ProcedureCompletedNCT02114073Phase 2
- Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II StudyCompletedNCT02113800Phase 2
- ASIS for Enbrel in Plaque PsoriasisStatus unknownNCT02112097Phase 1/2
- A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult SubjectsCompletedNCT02111317Phase 1
- Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With ExemestaneStatus unknownNCT02109913Not applicable
- Etanercept in Rheumatoid Arthritis and Vascular InflammationTerminatedNCT02109289Phase 4
- Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)CompletedNCT02108860Phase 3
- ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone AcetateCompletedNCT02106507Phase 1
- A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic DermatitisCompletedNCT02103725Phase 1
- Single Dose rATG for Renal Allograft RejectionStatus unknownNCT02102854Phase 4
- Bioavailability in Patient With Psoriasis: Metoject Prefilled PenCompletedNCT02097173Phase 1
- Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AMLActive, not recruitingNCT02094794Phase 2
- MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney TransplantationStatus unknownNCT02091973Not applicable
- Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With Dimethyl FumarateWithdrawnNCT02090348Phase 4
- Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma.Status unknownNCT02086942Phase 2
- PEG-ASP+Gemox Regimen and Thalidomide for NK/T LymphomaStatus unknownNCT02085655Phase 3
- Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal TransplantCompletedNCT02084446Phase 4
- Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell TransplantCompletedNCT02083250Phase 1
- Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple MyelomaWithdrawnNCT02082405Phase 2
- Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber SyndromeCompletedNCT02080624Phase 2
- Inflammation Control For Elders: ICE StudyWithdrawnNCT02079948Phase 2
- Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic TumorsCompletedNCT02077933Phase 1
- Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant PatientsCompletedNCT02077556Phase 4
- Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis PatientsCompletedNCT02076659Phase 1
- RCT of Methotrexate Added to Treatment As Usual in SchizophreniaCompletedNCT02074319Phase 1
- Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid LeukemiaStatus unknownNCT02072811Phase 3
- Efficacy and Safety of Abatacept in Patients With Primary Sjögren's SyndromeCompletedNCT02067910Phase 3
- Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver TransplantationStatus unknownNCT02064777Phase 4
- Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant PatientsWithdrawnNCT02062892Phase 4
- Study to Assess Safety and Efficacy of Fingolimod in Children With Rett SyndromeCompletedNCT02061137Phase 1/2
- NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell LiposarcomaWithdrawnNCT02059850Phase 1
- Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level MonitoringWithdrawnNCT02058875Phase 4
- Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT02057770Phase 1
- Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab TreatmentCompletedNCT02056587Phase 4
- Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney DiseaseStatus unknownNCT02055079Phase 3
- Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir BackgroundWithdrawnNCT02053727Not applicable
- Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis LymphomasStatus unknownNCT02049580Phase 2
- Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With ChemotherapyCompletedNCT02049047Phase 2
- Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and CyclophosphamideCompletedNCT02046915Phase 2
- A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese VolunteersCompletedNCT02046629Phase 1
- Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction RemissionStatus unknownNCT02044952Phase 2/3
- Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft RecipientsStatus unknownNCT02036554Phase 4
- A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant RecipientsCompletedNCT02034747Phase 4
- TNF-alpha Inhibition in CRPS: A Randomized Controlled TrialWithdrawnNCT02031211Not applicable
- N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/TopotecanCompletedNCT02030964Phase 1
- Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic AnaemiaStatus unknownNCT02028416Not applicable
- Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL WomenCompletedNCT02028364Phase 2
- Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II StudyWithdrawnNCT02027298Phase 2
- Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple MyelomaStatus unknownNCT02027220Phase 2
- Study of Sequential High-dose Chemotherapy in Children With High Risk MedulloblastomaTerminatedNCT02025881Phase 1/2
- Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast CancerStatus unknownNCT02025712Phase 2
- Efficacy Study of Leflunomide to Treat Juvenile Idiopathic ArthritisStatus unknownNCT02024334Phase 4
- Clinical Guidelines for APL TreatmentStatus unknownNCT02020161Phase 4
- Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain TumorsStatus unknownNCT02015728Not applicable
- Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and AdolescentsStatus unknownNCT02014506Phase 1/2
- A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC StudyStatus unknownNCT02013089Not applicable
- Pharmacokinetic Analysis of High Dose Methotrexate in Pediatric Lymphoblastic MalignanciesCompletedNCT02011022Not applicable
- A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed ChondrosarcomasSuspendedNCT02008019Phase 2
- Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)Status unknownNCT02005757Phase 2
- Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic DermatitisCompletedNCT02004860Phase 3
- Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye DiseaseCompletedNCT02004067Phase 4
- Efficacy and Safety of FTY720 for Acute StrokeCompletedNCT02002390Phase 2
- A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple MyelomaCompletedNCT01998971Phase 1
- Everolimus Post Orthotopic Liver TransplantStatus unknownNCT01998789Phase 2
- Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic AnemiaStatus unknownNCT01997372Phase 4
- Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)WithdrawnNCT01997255Phase 2
- Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic AnemiaStatus unknownNCT01995331Phase 4
- Preemptive Therapy of GVHDTerminatedNCT01994824Phase 2
- A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT01988961Phase 2
- Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast CancerTerminatedNCT01985841Phase 2
- Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast CancerCompletedNCT01985724Phase 3
- RCT on the Efficacy of Methotrexate for the Prevention of GTDCompletedNCT01984099Phase 3
- Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood TransplantationStatus unknownNCT01983761Phase 1/2
- Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid ScarsTerminatedNCT01978301Phase 1
- High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITPWithdrawnNCT01976195Phase 2